The Economics of Biologic Drugs
Alex Brill and Benedic N. Ippolito | Health Affairs Blog
The market for biologic drugs in the United States is large and growing. Total US biologic sales in 2018 is estimated to have been $125 billion, an increase of 50 percent since 2014. Given widespread public interest in curbing drug costs and drug spending, policymakers and others are keenly interested in the viability of biologic market competition to reduce prices.